Deep hematology/oncology drug development experience added with the appointment of Sherwin Sattarzadeh as Chief Operating Officer and Becker Hewes as Chief Medical Officer DMR-001, a potentially best-in-class mutant calreticulin (“mutCALR”) targeting monoclonal antibody, on track for IND submission in mid-2026 with anticipated first-in-human dosing via subcutaneous administration Cash balance, including $285 million raised in November 2025 PIPE, provides financial runway into 2029 to support multiple data m ...

OTA agreement provides for construction and operation of Project TETRA, Terrestrial Energy’s pilot reactor using Integral Molten Salt Reactor technology Terrestrial Energy now positioned to move quickly from design to operation under DOE authorization, laying the groundwork for swift commercialization of IMSR plants CHARLOTTE, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Terrestrial Energy Inc. (NASDAQ: IMSR) (“Terrestrial Energy” or “the Company”), a developer of small modular nuclear power plants using its Gen ...

SHENZHEN, China, Jan. 06, 2026 (GLOBE NEWSWIRE) -- CDT Environmental Technology Investment Holdings Limited (Nasdaq: CDTG) (“CDT”, the “Company”, or “we”), a leading provider of waste treatment systems and services throughout China, today announced that that it entered into share subscription agreements (each a “Share Subscription Agreement”) with six investors (each a “Subscriber”) on or around December 8, 2025, pursuant to which the Subscribers have agreed to subscribe in the aggregate 2,000,000 class A o ...

WALTHAM, Mass. and BOULDER, Colo., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that Andrew Robbins, President and Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026 at 8:15 a.m. PT/11:15 a.m. ET. A live webcast will be available on the Investors & Media page of Cogent’s website ...

RIDGEFIELD, Conn., Jan. 06, 2026 (GLOBE NEWSWIRE) -- The Chefs’ Warehouse, Inc. (NASDAQ: CHEF) (the “Company” or “Chefs’”), a premier distributor of specialty food products in the United States, the Middle East, and Canada, today announced that the Company will participate in a fireside chat at the ICR Conference in Orlando, FL on Tuesday, January 13, 2026. The fireside chat will begin at 11:30 a.m. ET. Investors and interested parties may listen to a webcast of the fireside chat by visiting the Company’s i ...

TERRE HAUTE, Ind., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Hallador Energy Company (Nasdaq: HNRG) (“Hallador” or the “Company”) today announced that its Board of Directors (the “Board”) has appointed Barbara Sugg to the Board, effective January 1, 2026. Ms. Sugg’s appointment follows the resignation of David Hardie from the Board, effective January 1, 2026. With the election of Ms. Sugg, Hallador’s Board remains at six total members, five of whom are independent under the Nasdaq listing standards. “On behalf of H ...

文章核心观点 Sow Good Inc 宣布完成一系列战略交易 旨在增强流动性 转向更轻资产的运营模式 并在继续运营糖果业务的同时 为评估增长机会和更广泛的战略替代方案提供灵活性 [1] 战略融资 - 公司于2025年12月31日与投资者David Lazar达成证券购买协议 完成600万美元的私募配资 融资将通过发行AA系列和AAA系列不可赎回可转换优先股分两期完成 每期300万美元 [2] - 第一期300万美元已于2025年12月31日完成 第二期300万美元预计在获得所需股东批准后 于2026年3月31日前完成 [3] - 私募所得净收益预计将用于资助持续运营 解决未偿债务 并维持公司持续经营的能力 [3] 资产出售与分销协议 - 公司已将其冷冻干燥零食和糖果业务的大部分相关资产出售给Trea Grove, LLC 总对价为150万美元 通过分期付款方式支付 截至2026年3月31日 [5] - 交易包括转让部分知识产权、不动产改良及其他相关资产 并由买方承担特定负债 [5] - 资产出售后 公司任命Trea Grove, LLC为特定产品的独家分销商 包括水果、零食和糖果 协议有效期至2026年7月31日（可延长） [6] - 根据协议 分销商将管理客户沟通、物流、履约、账单和收款 并将产品销售额总收入的10%汇给公司 [6] - 这些交易不构成清算或停止运营 公司将继续在正常业务过程中销售和分销其糖果产品 [7] 交易目的与战略展望 - 完成融资为公司提供了关键的运营缓冲和稳定性 公司当前重点是继续服务客户与合作伙伴 稳定业务 并评估糖果零食类别的增长机会 同时将探索能释放股东长期价值的额外战略替代方案 [4] - 业务转型使公司能够继续活跃于糖果市场 同时显著降低固定运营成本 该结构使公司能够通过第三方分销安排继续服务客户 在糖果行业内寻求增长机会 并审慎评估可能提升价值的其他战略路径 [8] - 完成这些交易后 公司将继续运营其糖果业务 同时评估糖果零食行业的增长机会 公司还将评估其他战略替代方案 包括潜在的合作、收购或其他公司交易 目标是加强其财务状况并创造长期股东价值 [11] 董事会与管理层变动 - David Lazar被任命为首席执行官兼董事会主席 [10] - Claudia Goldfarb辞去首席执行官职务 继续担任公司首席运营官兼董事会成员 [10] - David Lazar和David Natan当选为董事会成员 [10] - Joe Mueller和Chris Ludeman因相关交易辞去董事会职务 [10] - Ira Goldfarb辞去执行董事长兼董事会主席职务 [10] 公司背景 - Sow Good Inc 是一家总部位于美国的冷冻干燥零食和糖果行业领导者 致力于质量、创新和卓越 [12] - 公司的专有冷冻干燥技术和垂直整合制造平台生产一些在健康型和享受型零食类别中最令人兴奋的产品 所有产品均在德克萨斯州生产 [12]

A Next-Generation Certification Designed for Natural Retailers, Restaurants and Producers Committed to Responsible Sourcing and Verified Animal CareCASTLE ROCK, Colo., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Where Food Comes From, Inc. (WFCF) (Nasdaq: WFCF), the most trusted resource for independent, third-party verification of food production practices in North America, proudly announces the launch of RaiseWell® Certified, a comprehensive new standard that sets a new benchmark for animal care, verified natural r ...

MIAMI, FL, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company, is issuing a formal directive to all financial data providers, news aggregators, and brokerage platforms to reconcile their databases with the Company’s established pharmaceutical operations. Following a fundamental strategic pivot initiated in 2022, the Company has fully transitioned away from legacy industries and is now operating within the healthcare and pharmaceutica ...

Clinical trial evaluating changes in urine protein-to-creatinine ratio, a widely-accepted endpoint measuring risk reduction of kidney failureCAMBRIDGE, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the first patient has been dosed in a Phase 2 clinical trial of praliciguat, an oral, once-daily soluble guanylate cyclase (sGC) stimulator being evalua ...